“…A national study showed that 78% of clinicians felt that their patients would refuse to disclose their SGM status, in stark contrast to only 10% of patients reporting that they would refuse to disclose their status, citing improved individualized care as a benefit to disclosure. [10][11][12] In a recent national survey of nearly 150 oncologists from National Cancer Institute-designated cancer centers across the United States, Schabath and colleagues measured the attitudes, knowledge, institutional practice behaviors, and interest in education on the care of LGBTQ patients with cancer. 13 They found that although a majority of oncologists, approximately two-thirds, felt that it was important to know a patient's gender identity, only about one-third felt that it was relevant to them to know of the patient's sexual orientation.…”